Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$10.95 -1.26%
Market Cap
$55.9M
Price Target
Refer to Report
Volume
2.2K
52wk Range
$8.4801 - $16.98
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.